Treatment of schizoaffective disorders.
Treatment of schizoaffective disorders.
复制标题
分裂情感障碍的治疗。
DOI：
--
复制
发表时间：
1984
影响因子：
6.6
通讯作者：
Herbert Y. Meltzer
中科院分区：
文献类型：
--
作者：
Paul J. Goodnick;Herbert Y. Meltzer
对诊断为原发性情感障碍和分裂情感障碍的患者的治疗反应进行了比较的研究综述。尽管对分裂情感性精神障碍的化疗进行的对照或非对照研究相对较少，但现有证据表明：(1)碳酸锂对分裂情感性躁狂和躁狂都有效；(2)单独抗抑郁药、单用神经抗抑郁剂或它们的组合对分裂情感性抑郁症和原发性抑郁症的初期治疗都有效；(3)预防性服用碳酸锂可以减少分裂情感性躁狂和分裂情感性抑郁症患者的复发频率和复发持续时间。因此，治疗研究表明，分裂情感性障碍与原发情感性障碍对药物治疗的反应非常相似。本实验室的证据表明，分裂情感躁狂症患者比躁狂症患者对锂或抗精神病药物的治疗反应更慢。
Studies that compare the treatment response of patients diagnosed as primary affective disorder or schizoaffective disorder are reviewed. Although relatively few controlled or uncontrolled studies of the chemotherapy of schizoaffective disorders have been conducted, available evidence suggests that: (1) lithium carbonate is effective in the initial treatment of both schizoaffective mania and mania; (2) antidepressants alone, neuroleptics alone, or their combination can be effective in the initial treatment of both schizoaffective depression and primary depression; and (3) prophylactic administration of lithium carbonate may reduce the frequency and duration of relapse in both schizoaffective manic and schizoaffective depressed patients. Thus, treatment studies indicate that the schizoaffective disorders are very similar to the primary affective disorders with regard to response to pharmacologic treatment. Evidence from this laboratory that schizoaffective manic patients respond more slowly than manic patients to lithium or neuroleptic treatment is presented.
“分裂情感障碍”：诊断无效？
DOI：
10.1176/ajp.137.8.921
发表时间：
1980
期刊：
The American journal of psychiatry
影响因子：
--
作者：
PopeJr,HG;Lipinski,JF;Cohen,BM;Axelrod,DT
通讯作者：
Axelrod,DT